Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene

This study has been completed.
Information provided by:
Sanofi Identifier:
First received: August 29, 2006
Last updated: May 15, 2008
Last verified: May 2008

August 29, 2006
May 15, 2008
June 2006
Not Provided
Adverse Events and its association with the drug in study
Same as current
Complete list of historical versions of study NCT00370162 on Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata New Fragrance
The purpose of this study is to demonstrate the safety of the gynaecological formulation in normal and usual usage condition.
Not Provided
Phase 3
Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Drug: lactoserum
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Not Provided
Not Provided

Inclusion Criteria:

  • Integral skin in the tested region

Exclusion Criteria:

  • Pregnancy or breastfeeding women
  • Use of antiinflammatory or immunosuppression drugs
  • Topical medication use at the tested region
  • Active cutaneous gynaecological disease
  • Personal history of allergic disease at the area to be treated
  • Allergic or atopic history
18 Years to 60 Years
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Study Director: Jaderson Lima Sanofi
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP